Cargando…

PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients

BACKGROUND: Phosphoglucomutase (PGM), a key enzyme in the metabolism of glucose-1-phosphate and glucose-6-phosphate, has been found to be associated with proliferation, invasion, and metastasis of cancer. However, the expression and function of PGM5 in colorectal cancer (CRC) remains unknown. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yifan, Long, Haihua, Sun, Lin, Sun, Xiujuan, Pang, Liping, Chen, Jianlin, Yi, Qingqun, Liang, Tianwei, Shen, Yongqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771116/ https://www.ncbi.nlm.nih.gov/pubmed/31582909 http://dx.doi.org/10.1186/s12935-019-0967-y

Ejemplares similares

PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway
por: Zheng, Zhewen, et al.
Publicado: (2022)

Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation
por: Lin, Xia-Hui, et al.
Publicado: (2023)

Knockdown of PGM1 enhances anticancer effects of orlistat in gastric cancer under glucose deprivation
por: Cao, Bo, et al.
Publicado: (2021)

Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico
por: Chen, Jingxuan, et al.
Publicado: (2020)

Meta-analysis of the effect of PGM on survival prognosis of tumor patients
por: Zheng, Zhewen, et al.
Publicado: (2022)

NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma
por: Zhao, Cui, et al.
Publicado: (2021)

A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer
por: Liu, Lei, et al.
Publicado: (2021)

Identification of crucial genes of pyrimidine metabolism as biomarkers for gastric cancer prognosis
por: Wu, Zhengxin, et al.
Publicado: (2021)

Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma
por: Cheng, Xingbo, et al.
Publicado: (2022)

High CTHRC1 expression may be closely associated with angiogenesis and indicates poor prognosis in lung adenocarcinoma patients
por: Chen, Yangshan, et al.
Publicado: (2019)

Aberrantly methylated-differentially expressed genes and pathways in colorectal cancer
por: Liu, Jingwei, et al.
Publicado: (2017)

Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer
por: Sun, Jian, et al.
Publicado: (2022)

Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
por: Zhang, Han, et al.
Publicado: (2021)

Targeted delivery of immuno-RNase may improve cancer therapy
por: Sun, Miaonan, et al.
Publicado: (2018)

Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma
por: Ma, Rong, et al.
Publicado: (2019)

Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients
por: Huang, Biao, et al.
Publicado: (2020)

XPF expression and its relationship with the risk and prognosis of colorectal cancer
por: Hu, Huixin, et al.
Publicado: (2021)

Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
por: Hong, Weifeng, et al.
Publicado: (2020)

PGM5: a novel diagnostic and prognostic biomarker for liver cancer
por: Jiao, Yan, et al.
Publicado: (2019)

Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer
por: Chen, Jianlin, et al.
Publicado: (2022)

Identification of a 6-gene signature predicting prognosis for colorectal cancer
por: Zuo, Shuguang, et al.
Publicado: (2019)

Biomarker implication of kallikrein-related peptidases as prognostic tissue substrates of poor survival in colorectal cancer
por: Peng, Qiliang, et al.
Publicado: (2020)

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
por: Zheng, Qiuxian, et al.
Publicado: (2021)

MiR-7 inhibits progression of hepatocarcinoma by targeting KLF-4 and promises a novel diagnostic biomarker
por: Wu, Weizhong, et al.
Publicado: (2017)

Establishment and validation of a novel nomogram incorporating clinicopathological parameters into the TNM staging system to predict prognosis for stage II colorectal cancer
por: Mo, Shaobo, et al.
Publicado: (2020)

Upregulation of SNTB1 correlates with poor prognosis and promotes cell growth by negative regulating PKN2 in colorectal cancer
por: Liu, Liya, et al.
Publicado: (2021)

UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer
por: Zhao, Ya-li, et al.
Publicado: (2019)

Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma
por: Guo, Lingyun, et al.
Publicado: (2020)

ITGB1-DT/ARNTL2 axis may be a novel biomarker in lung adenocarcinoma: a bioinformatics analysis and experimental validation
por: Qiu, Bai-Quan, et al.
Publicado: (2021)

Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma
por: Shi, Jinyuan, et al.
Publicado: (2021)

Expression profile analysis of two antisense lncRNAs to improve prognosis prediction of colorectal adenocarcinoma
por: Shademan, Milad, et al.
Publicado: (2019)

Integrated analyses of microRNA-29 family and the related combination biomarkers demonstrate their widespread influence on risk, recurrence, metastasis and survival outcome in colorectal cancer
por: Peng, Qiliang, et al.
Publicado: (2019)

DNA methylation biomarkers for hepatocellular carcinoma
por: Fan, Guorun, et al.
Publicado: (2018)

FOXD3 may be a new cellular target biomarker as a hypermethylation gene in human ovarian cancer
por: Luo, Gui-fang, et al.
Publicado: (2019)

Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma
por: Gao, Chundi, et al.
Publicado: (2018)

The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients
por: Yang, Li-Rong, et al.
Publicado: (2022)

Establishment of a 5-gene risk model related to regulatory T cells for predicting gastric cancer prognosis
por: Hu, Gang, et al.
Publicado: (2020)

Identification of NEO1 as a prognostic biomarker and its effects on the progression of colorectal cancer
por: Zhang, Meng, et al.
Publicado: (2020)

A 3-circular RNA signature as a noninvasive biomarker for diagnosis of colorectal cancer
por: Ye, Dao-xiong, et al.
Publicado: (2019)

Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma
por: Yan, Tao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tc06c2ok922er5f3setv7n6bev